Last reviewed · How we verify

NCT05688150

Prevalence and Associated Factors of Sarcopenia Among Elderly Patients in Osteoporosis Clinic

Completed Last updated 20 February 2024
What this trial tests

trial in Sarcopenia in 94 participants. Completed in 28 February 2023.

Timeline
20 June 2022
Primary endpoint
12 December 2022
28 February 2023

Quick facts

Lead sponsorKowloon Hospital, Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment94
Start date20 June 2022
Primary completion12 December 2022
Estimated completion28 February 2023
Sites1 location across Hong Kong

Conditions studied

Sponsor

Kowloon Hospital, Hong Kong

Who can join

60 and older, any sex, with Sarcopenia or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a cross-sectional study. Patients who attended the osteoporosis clinic of Kowloon Hospital from June to December 2022 were recruited. Grip strength and appendicular skeletal muscle mass index were measured with a Jamar dynamometer and a bioimpedance analyser. Since most patients in our clinic are of Chinese ethnicity, the diagnostic criteria in the Consensus Update on Sarcopenia Diagnosis and Treatment by the Asian Working Group for Sarcopenia in 2019 was utilised. The diagnosis of sarcopenia was established by the presence of both low grip strength (Male: \< 28 kg, Female \< 18 kg) and low appendicular skeletal mass (Male: \< 7.0 kg/m2, Female: \< 5.7 kg/m2)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Kowloon Hospital, Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05688150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing